RecruitingPhase 2NCT06976619
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
Sponsor: Mayo Clinic
Rochester, MN
Phase 2 Type 1 Diabetes clinical trials
26 recruiting Phase 2 type 1 diabetes studies in the US. What trial phases mean
Other phases
RecruitingPhase 2NCT05478707
Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes
Sponsor: AdventHealth Translational Research Institute
Orlando, FL
RecruitingPhase 2NCT07187531
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Sponsor: SAb Biotherapeutics, Inc.
San Francisco, CA · San Jose, CA · Aurora, CO · +19 more sites
RecruitingPhase 2NCT07699380
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
Sponsor: University of Washington
Seattle, WA
RecruitingPhase 2NCT07216391
Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Aurora, CO · New Haven, CT · Gainesville, FL · +3 more sites
RecruitingPhase 2NCT07142252
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
San Francisco, CA · Aurora, CO · New Haven, CT · +11 more sites
RecruitingPhase 2NCT05414409
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
Sponsor: Heba M. Ismail
Indianapolis, IN
RecruitingPhase 2NCT07224321
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
Sponsor: Mannkind Corporation
Los Angeles, CA · San Francisco, CA · Aurora, CO · +7 more sites
RecruitingPhase 2NCT06411210
Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment
Sponsor: Yale University
New Haven, CT
RecruitingPhase 2NCT05822609
Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
Sponsor: University of Washington
Aurora, CO · Seattle, WA · Spokane, WA
RecruitingPhase 2NCT04933851
ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes
Sponsor: Scripps Whittier Diabetes Institute
San Diego, CA
RecruitingPhase 2NCT05762107
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Sponsor: Zucara Therapeutics Inc.
Birmingham, AL · Little Rock, AR · Escondido, CA · +35 more sites
RecruitingPhase 2NCT06964087
Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
Sponsor: Op-T LLC
Birmingham, AL · Walnut Creek, CA · Aurora, CO · +2 more sites
RecruitingPhase 2NCT03970720
Restoration of Hypoglycemia Awareness With Metoclopramide
Sponsor: Simon Fisher
Lexington, KY · Salt Lake City, UT
RecruitingPhase 2NCT07186660
Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes
Sponsor: University of Virginia
Charlottesville, VA
RecruitingPhase 2NCT01241864
Islet Transplantation in Type 1 Diabetic Kidney Allograft
Sponsor: University of Chicago
Chicago, IL
RecruitingPhase 2NCT06455319
Precision Administration of Anti-thymocyte Globulin With or Without Verapamil
Sponsor: University of Florida
Aurora, CO · Gainesville, FL
RecruitingPhase 2NCT06981234
Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial
Sponsor: University of California, San Diego
La Jolla, CA
RecruitingPhase 2NCT06810726
Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.
Sponsor: Estar Medical dba Medical Technologies, LTD
Corpus Christi, TX
Not yet recruitingPhase 2NCT07616206
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Who Are Using Hybrid Closed Loop (HCL) Systems
Sponsor: vTv Therapeutics
Atlanta, GA
Not yet recruitingPhase 2NCT07808151
Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
Sponsor: Solstice Oncology, Inc.
Los Angeles, CA · Tampa, FL · Chicago, IL · +8 more sites
Not yet recruitingPhase 2NCT07325201
Mitigating DKA in Type 1 Diabetes for Safe Use of SGLT Inhibitors Using Dual Continuous Ketone and Glucose Monitoring.
Sponsor: HealthPartners Institute
Minneapolis, MN
Not yet recruitingPhase 2NCT07594145
Precision T1D Platform - New Therapies for Cardio-Renal Complications
Sponsor: Oregon Health and Science University
Ann Arbor, MI · Portland, OR
Not yet recruitingPhase 2NCT07683026
Platform Trial in Stage 1 Diabetes: Comparing Golimumab vs Placebo
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Boston, MA
Not yet recruitingPhase 2NCT07430332
GLP-1 RA for Stage 1 Type 1 Diabetes
Sponsor: Children's Hospital Medical Center, Cincinnati
Cincinnati, OH
Not yet recruitingPhase 2NCT07421518
Ketone Monitoring Approaches for Diabetic Ketoacidosis Risk Mitigation in People With T1D on Adjunctive SGLT-2 Inhibitors
Sponsor: AdventHealth Translational Research Institute
Orlando, FL
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.